These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 11368253)

  • 21. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Different bronchodilating effect of salmeterol and formoterol in an adult asthmatic.
    Ulrik CS; Kok-Jensen A
    Eur Respir J; 1994 May; 7(5):1003-5. PubMed ID: 7914175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
    Pearlman DS; Stricker W; Weinstein S; Gross G; Chervinsky P; Woodring A; Prillaman B; Shah T
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Salmeterol: a novel, long-acting beta 2-agonist.
    Meyer JM; Wenzel CL; Kradjan WA
    Ann Pharmacother; 1993 Dec; 27(12):1478-87. PubMed ID: 7905757
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing bronchospasm with short-acting beta(2)-agonists.
    Fitzgerald MA
    Nurse Pract; 2006 Sep; 31(9):47-53. PubMed ID: 16971833
    [No Abstract]   [Full Text] [Related]  

  • 26. Lack of subsensitivity to albuterol after treatment with salmeterol in patients with asthma.
    Nelson HS; Berkowitz RB; Tinkelman DA; Emmett AH; Rickard KA; Yancey SW
    Am J Respir Crit Care Med; 1999 May; 159(5 Pt 1):1556-61. PubMed ID: 10228126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease.
    Cazzola M; Centanni S; Boveri B; Di Marco F; Santus P; Matera MG; Allegra L
    Respiration; 2001; 68(5):452-9. PubMed ID: 11694805
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of oral bambuterol and inhaled salmeterol in patients with symptomatic asthma and using inhaled corticosteroids.
    Crompton GK; Ayres JG; Basran G; Schiraldi G; Brusasco V; Eivindson A; Jamieson AH; Olsson H
    Am J Respir Crit Care Med; 1999 Mar; 159(3):824-8. PubMed ID: 10051257
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma.
    Markham A; Jarvis B
    Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Fowler SJ; Lipworth BJ
    JAMA; 2001 Dec; 286(24):3076-7; author reply 3077-8. PubMed ID: 11754665
    [No Abstract]   [Full Text] [Related]  

  • 31. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Miller FG; Shorr AF
    JAMA; 2001 Dec; 286(24):3075-6; author reply 3077-8. PubMed ID: 11754663
    [No Abstract]   [Full Text] [Related]  

  • 32. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Friedman Ross L
    JAMA; 2001 Dec; 286(24):3076; author reply 3077-8. PubMed ID: 11754664
    [No Abstract]   [Full Text] [Related]  

  • 33. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Botkin JR; Clayton E; Nelson R; Wilfond B; Munger MA
    JAMA; 2001 Dec; 286(24):3075; author reply 3077-8. PubMed ID: 11754662
    [No Abstract]   [Full Text] [Related]  

  • 34. Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England.
    Twaites BR; Wilton LV; Shakir SA
    Drug Saf; 2007; 30(5):419-29. PubMed ID: 17472420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Salmeterol xinafoate vs albuterol in asthma: was race a factor?
    Olopade CO
    JAMA; 1994 Nov 23-30; 272(20):1576. PubMed ID: 7966862
    [No Abstract]   [Full Text] [Related]  

  • 36. Bronchodilator treatment and deaths from asthma: case-control study.
    Anderson HR; Ayres JG; Sturdy PM; Bland JM; Butland BK; Peckitt C; Taylor JC; Victor CR
    BMJ; 2005 Jan; 330(7483):117. PubMed ID: 15618231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparison of beclomethasone, salmeterol, and placebo in children with asthma. Canadian Beclomethasone Dipropionate-Salmeterol Xinafoate Study Group.
    Simons FE
    N Engl J Med; 1997 Dec; 337(23):1659-65. PubMed ID: 9385125
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchodilating effect of formoterol but not of salmeterol in two asthmatic patients.
    Noppen M; Vincken W
    Respiration; 2000; 67(1):112-3. PubMed ID: 10705276
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety of salmeterol in the maintenance treatment of asthma.
    Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
    Holimon TD; Chafin CC; Self TH
    Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.